VERTEX PHARMACEUTICALS INC / MA Proceeds from Stock Issuance 2008-2025 | VRTX
Beta
What is VERTEX PHARMACEUTICALS INC / MA's current proceeds from stock issuance?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual proceeds from stock issuance for 2025 was $55.6M, a 11.20% increase from 2024. VERTEX PHARMACEUTICALS INC / MA proceeds from stock issuance for the quarter ending December 31, 2009 was $488.1M.
What was VERTEX PHARMACEUTICALS INC / MA's proceeds from stock issuance in 2024?
VERTEX PHARMACEUTICALS INC / MA annual proceeds from stock issuance for 2024 was $50.0M, a 38.12% decline from 2023.
What was VERTEX PHARMACEUTICALS INC / MA's proceeds from stock issuance in 2023?
VERTEX PHARMACEUTICALS INC / MA annual proceeds from stock issuance for 2023 was $80.8M, a 44.12% decline from 2022.
What is VERTEX PHARMACEUTICALS INC / MA's 5-year proceeds from stock issuance CAGR?
VERTEX PHARMACEUTICALS INC / MA proceeds from stock issuance grew at a compound annual growth rate (CAGR) of 24.60% from FY2020 to FY2025, going from $228.2M to $55.6M over 5 years.
Proceeds from Stock Issuance History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR-24.6%
FY2020
$228.2M
→
FY2025
$55.6M
08091516171819202122232425
5 years selected
Proceeds from Stock Issuance History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $55.6M | +11.2% | 10-K |
| FY2024 | $50.0M | -38.1% | 10-K |
| FY2023 | $80.8M | -44.1% | 10-K |
| FY2022 | $144.6M | +125.2% | 10-K |
| FY2021 | $64.2M | -71.9% | 10-K |
| FY2020 | $228.2M | -28.2% | 10-K |
| FY2019 | $317.8M | +20.7% | 10-K |
| FY2018 | $263.4M | -18.5% | 10-K |
| FY2017 | $323.3M | +566.6% | 10-K |
| FY2016 | $48.5M | -70.7% | 10-K |
| FY2015 | $165.6M | -79.3% | 10-K |
| FY2009 | $801.4M | +142.7% | 10-K |
| FY2008 | $330.1M | - | 10-K |
Company: VERTEX PHARMACEUTICALS INC / MATicker: VRTXSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →